78 related articles for article (PubMed ID: 15036166)
1. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study.
Quittenbaum BH; Grahn B
Parkinsonism Relat Disord; 2004 Mar; 10(3):129-36. PubMed ID: 15036166
[TBL] [Abstract][Full Text] [Related]
2. Pain in Parkinson disease: a deep phenotyping study.
Salabasidou E; Binder T; Volkmann J; Kuzkina A; Üçeyler N
Pain; 2024 Jul; 165(7):1642-1654. PubMed ID: 38314763
[TBL] [Abstract][Full Text] [Related]
3. Pain in monogenic Parkinson's disease: a comprehensive review.
Alizadeh P; Terroba-Chambi C; Achen B; Bruno V
Front Neurol; 2023; 14():1248828. PubMed ID: 38020640
[TBL] [Abstract][Full Text] [Related]
4. Musculoskeletal pain in Parkinson's disease: a narrative review.
Tueth LE; Duncan RP
Neurodegener Dis Manag; 2021 Oct; 11(5):373-385. PubMed ID: 34410146
[TBL] [Abstract][Full Text] [Related]
5. Motor Cortex Stimulation Reversed Hypernociception, Increased Serotonin in Raphe Neurons, and Caused Inhibition of Spinal Astrocytes in a Parkinson's Disease Rat Model.
Campos ACP; Berzuíno MB; Barbosa GR; Freire HMRC; Lopes PS; Assis DV; Fonoff ET; Pagano RL
Cells; 2021 May; 10(5):. PubMed ID: 34064617
[TBL] [Abstract][Full Text] [Related]
6. Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson's disease: implication of acrolein and TRPA1.
Shi L; Lin Y; Jiao Y; Herr SA; Tang J; Rogers E; Chen Z; Shi R
Transl Neurodegener; 2021 Apr; 10(1):13. PubMed ID: 33910636
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies.
Zhao N; Yang Y; Zhang L; Zhang Q; Balbuena L; Ungvari GS; Zang YF; Xiang YT
CNS Neurosci Ther; 2021 Mar; 27(3):270-279. PubMed ID: 33372386
[TBL] [Abstract][Full Text] [Related]
8. Conditioned pain modulation in drug-naïve patients with de novo Parkinson's disease.
Grashorn W; Fründt O; Buhmann C; Wrobel N; Schmidt K; Bingel U
Neurol Res Pract; 2019; 1():27. PubMed ID: 33324893
[TBL] [Abstract][Full Text] [Related]
9. Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease.
Mehdizadeh M; Fereshtehnejad SM; Goudarzi S; Moshtagh A; Dehghanian Nasrabadi F; Habibi SAH; Taghizadeh G
Parkinsons Dis; 2020; 2020():2793945. PubMed ID: 32908666
[TBL] [Abstract][Full Text] [Related]
10. Symptom burden among individuals with Parkinson disease: A national survey.
Tarolli CG; Zimmerman GA; Auinger P; McIntosh S; Horowitz RK; Kluger BM; Dorsey ER; Holloway RG
Neurol Clin Pract; 2020 Feb; 10(1):65-72. PubMed ID: 32190422
[TBL] [Abstract][Full Text] [Related]
11. Connectivity Patterns of Subthalamic Stimulation Influence Pain Outcomes in Parkinson's Disease.
Cury RG; Teixeira MJ; Galhardoni R; Silva V; Iglesio R; França C; Arnaut D; Fonoff ET; Barbosa ER; Ciampi de Andrade D
Front Neurol; 2020; 11():9. PubMed ID: 32116998
[No Abstract] [Full Text] [Related]
12. Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.
Buhidma Y; Rukavina K; Chaudhuri KR; Duty S
NPJ Parkinsons Dis; 2020; 6():1. PubMed ID: 31934609
[TBL] [Abstract][Full Text] [Related]
13. The phenomenology of pain in Parkinson's disease.
Camacho-Conde JA; Campos-Arillo VM
Korean J Pain; 2020 Jan; 33(1):90-96. PubMed ID: 31888323
[TBL] [Abstract][Full Text] [Related]
14. Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson's disease.
Cuomo A; Crispo A; Truini A; Natoli S; Zanetti O; Barone P; Cascella M
J Pain Res; 2019; 12():2201-2209. PubMed ID: 31413618
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.
Martinez-Martin P; Rizos AM; Wetmore JB; Antonini A; Odin P; Pal S; Sophia R; Carroll C; Martino D; Falup-Pecurariu C; Kessel B; Andrews T; Paviour D; Trenkwalder C; Chaudhuri KR;
Mov Disord Clin Pract; 2019 Jan; 6(1):57-64. PubMed ID: 30746417
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Assessment of Function and Disability in Patients with Parkinson's Disease Using the Functioning Disability Evaluation Scale-Adult Version.
Hsu TH; Liou TH; Chou KR; Chi WC; Yen CF; Liao HF; Tseng IJ
Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30544859
[TBL] [Abstract][Full Text] [Related]
17. Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations.
Perez-Lloret S; Ciampi de Andrade D; Lyons KE; Rodríguez-Blázquez C; Chaudhuri KR; Deuschl G; Cruccu G; Sampaio C; Goetz CG; Schrag A; Martinez-Martin P; Stebbins G;
Mov Disord Clin Pract; 2016; 3(6):527-537. PubMed ID: 30363588
[TBL] [Abstract][Full Text] [Related]
18. Clinical pain and functional network topology in Parkinson's disease: a resting-state fMRI study.
Engels G; McCoy B; Vlaar A; Theeuwes J; Weinstein H; Scherder E; Douw L
J Neural Transm (Vienna); 2018 Oct; 125(10):1449-1459. PubMed ID: 30132078
[TBL] [Abstract][Full Text] [Related]
19. Non-Motor Symptoms of Parkinson's Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients.
Tibar H; El Bayad K; Bouhouche A; Ait Ben Haddou EH; Benomar A; Yahyaoui M; Benazzouz A; Regragui W
Front Neurol; 2018; 9():170. PubMed ID: 29670566
[TBL] [Abstract][Full Text] [Related]
20. Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale.
Martinez-Martin P; Manuel Rojo-Abuin J; Rizos A; Rodriguez-Blazquez C; Trenkwalder C; Perkins L; Sauerbier A; Odin P; Antonini A; Chaudhuri KR;
NPJ Parkinsons Dis; 2017; 3():8. PubMed ID: 28649608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
